Hyper-CVAD combined with Venetoclax for relapsed pediatric blastic plasmacytoid dendritic cell neoplasm (BPDCN): A case report and literature review.

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) is a very rare type of leukemia in children, Although BPDCN is a chemo-sensitive tumor, the relapse rate is very high. Tagraxofusp, which is a CD123-directed cytotoxin has been used as a targeted therapy and has shown promising results in patients...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Dima Abla, Miguel R. Abboud, Dolly Noun, Nidale Tarek, Naveen Pemmaraju
Формат: Artigo
Язык:Inglês
Опубликовано: Elsevier 2022-01-01
Серии:Leukemia Research Reports
Предметы:
Plasmacytoid
Dendritic
Neoplasm
Leukemia
Venetoclax
Online-ссылка:http://www.sciencedirect.com/science/article/pii/S2213048922000255
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы